Company profile for Orogen Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Orogen Therapeutics is transforming small-molecule drug discovery with its proprietary FocusDEL™ platform, a powerful integration of DNA-encoded libraries, virtual screening, and custom chemical design, all supercharged by AI and expert-driven innovation. Our goal is to swiftly identify novel therapeutic compounds targeting disease areas like inflammation and immune dysfunction. Anchored in rigorous experimental science and ...
Orogen Therapeutics is transforming small-molecule drug discovery with its proprietary FocusDEL™ platform, a powerful integration of DNA-encoded libraries, virtual screening, and custom chemical design, all supercharged by AI and expert-driven innovation. Our goal is to swiftly identify novel therapeutic compounds targeting disease areas like inflammation and immune dysfunction. Anchored in rigorous experimental science and machine-guided insights, Orogen is dedicated to delivering groundbreaking clinical solutions for serious unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
12 Gill St Suite 4200 Woburn MA 01801
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250716264196/en/Orogen-Therapeutics-and-ChemspaceEnamine-Announce-a-Strategic-Collaboration-to-Enable-Unique-REAL-Driven-DNA-Encoded-Small-Molecule-Libraries

BUSINESSWIRE
16 Jul 2025

https://www.businesswire.com/news/home/20250507175901/en/Orogen-Therapeutics-Announces-Expansion-of-Board-with-Biopharma-Leaders-Mikael-Dolsten-and-Dieter-Weinand-as-Independent-Non-Executive-Directors.

BUSINESSWIRE
07 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty